Phase 3 study for adenocarcinoma of stomach or GE junction

The primary objective of this trial is to demonstrate superiority of maintenance therapy with avelumab versus continuation of first-line chemotherapy with regard to Overall Survival (OS) in subjects who have not progressed on first-line chemotherapy

August 09, 2017